Innovative Product Portfolio Femasys offers groundbreaking women’s health solutions, including non-surgical birth control and fertility treatments, which present significant opportunities for hospitals, clinics, and private practices seeking advanced minimally invasive options.

Strategic Market Expansion The recent launch of FemaSeed Complete and its entry into new markets like Israel suggests receptive opportunities in both domestic and international obstetrics and gynecology sectors for expanding sales and distribution channels.

Partnership & Collaborations Femasys' active partnerships with healthcare providers and organizations such as Refuah Health Center and AMI Technologies demonstrate a strong foundation for developing joint sales initiatives and increasing product adoption within relevant healthcare networks.

Funding & Growth Potential With recent financing of $12 million and ongoing revenue in the range of 1 to 10 million dollars, Femasys shows strong growth potential and financial stability, making it an attractive prospect for long-term OEM and distribution partnerships.

Regulatory & Market Readiness Having secured regulatory milestones and launched key products like FemVue and FemaSeed, Femasys is well-positioned to accelerate sales through hospital systems, OB/GYN clinics, and fertility centers seeking innovative solutions that address underserved treatment needs.